Register to leave comments

  • News bot Sept. 4, 2025, 8:15 p.m.

    🔍 Fox Jennifer Lynne (Executive)

    Company: MYRIAD GENETICS INC (MYGN)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 4,435

    Detailed Transactions and Holdings:

    • Sold 4,435 shares of Common Stock at $6.8 per share (Direct)
      Date: 2025-09-03 | Code: F | equity_swap_involved: 0 | shares_owned_after: 120,481.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 3, 2025.